Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pak J Pharm Sci ; 26(2): 239-43, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23455190

RESUMO

Tobacco smoking represents major national and international health hazard that interferes with wide range of physiological functions and biomarkers. In the current study we have investigated the influence of tobacco smoking on some biological markers such as serum amyloid protein-A, rheumatoid factor, serum glucose level and lipid profile in Saudi population. The fore mentioned parameters were investigated in a total of 275 cases in 3 different age categories (less than 20 years old, 20-40 years old and older than 40 years old). Long term survey was adopted in all cases; yet, lightly smoking and heavily smoking groups were compared to never smoking healthy population. Results obtained showed significant increase in serum amyloid protein-A and rheumatoid factor in correlation to the degree of smoking nonetheless in the age category older than 40 years old. Serum glucose, triglyceride, and total cholesterol was not affected by smoking in all studied age categories; however serum LDL-cholesterol was elevated and serum HDL-cholesterol was depressed in correlation to the degree of smoking in all age categories. In conclusion, tobacco smoking represents major cardiovascular risk factor in Saudi population in all age categories and serum amyloid protein-A and rheumatoid factor might be used as a serological surrogate marker for such risk.


Assuntos
Doenças Cardiovasculares/epidemiologia , Fator Reumatoide/sangue , Proteína Amiloide A Sérica/análise , Fumar/sangue , Adolescente , Adulto , Fatores Etários , Idoso , Análise de Variância , Biomarcadores/sangue , Glicemia/análise , Humanos , Lipídeos/sangue , Masculino , Pessoa de Meia-Idade , Prognóstico , Medição de Risco , Fatores de Risco , Arábia Saudita/epidemiologia , Fumar/efeitos adversos , Fumar/epidemiologia , Regulação para Cima , Adulto Jovem
2.
Pak J Pharm Sci ; 23(4): 359-62, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20884446

RESUMO

Non-CYP oxidase enzymes are important system in biotransformation of drugs and environmental pollutants. Molybdenum containing oxidase enzymes such as aldehyde oxidase and xanthine oxidase are constitutive tissue enzymes that metabolize several drug moieties. Herein, we evaluated the circadian rhythm of these two enzymes in mice liver using different substrate/oxygen donor couples. Aldehyde oxidase showed typical rhythmic fluctuation with peak activity at night cycle and minimum activity at light cycle using pthalazine/ferricyanide and 3-methylisoquinoline/ferricyanide substrates. On the other hand, xanthine oxidase showed interrupted diurnal rhythm, however peak and minimum enzyme activities were similar to aldehyde oxidase circadian rhythm. In conclusion, diurnal rhythm of both molybdenum hydroxylase enzymes was confirmed and validated in mice liver tissue that might provide further insights in the experimental evaluation of phase-I pharmacokinetics for new drugs.


Assuntos
Aldeído Oxidase/metabolismo , Ritmo Circadiano/fisiologia , Fígado/enzimologia , Oxigenases de Função Mista/metabolismo , Xantina Oxidase/metabolismo , Animais , Poluentes Ambientais/metabolismo , Ferricianetos/metabolismo , Masculino , Camundongos , Oxirredução , Consumo de Oxigênio/fisiologia , Preparações Farmacêuticas/metabolismo , Ftalazinas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...